Key result
Among primary care patients with type 2 diabetes, a 10-unit increase in depressive symptom severity was significantly associated with a 0.26 percentage point increase in HbA1c.
Why the study?
Hungarian primary care data on the prevalence of depression and anxiety symptoms and their impact on glycemic control in diabetes were lacking.
Cross-Sectional (n=338)
Yes
Among primary care patients with type 2 diabetes, more severe depressive symptoms, but not anxiety symptoms, are independently associated with worse glycemic control.
Answers are grounded in this paper and cite their sources.
Depressive symptom screening may flag poorer glycemic control in Hungarian primary care; leaves open whether treating depression improves HbA1c.
Background Data from primary care regarding the prevalence of symptoms of depression and anxiety, and their effect on glycemic control among people with diabetes is lacking in Hungary. The recently introduced Patient Health Record (PHR) requires family doctors to screen for depressive symptoms. Objectives We aimed to investigate the prevalence of depressive and anxiety symptoms among patients with type 2 diabetes in the general practice, and the relationship between these affective disorders and glycated hemoglobin (HbA1c) level. Methods We included 338 consecutive patients with type 2 diabetes from six primary care practices in this cross-sectional study. A self-administered questionnaire (patient history, anthropometric, socioeconomic, laboratory parameters), the Beck Depression Inventory (BDI) and the Hamilton Anxiety Scale (HAM-A) were used. Results The mean age of the sample was 64.0 ± 11.5 (years ± SD), 61% of participants were female. The prevalence of depressive symptoms was 21%, mainly moderate/severe symptoms (13%). Anxiety symptoms were more common (35%). We found significant univariate association between the depressive symptoms and HbA1c ( p = 0.001), suicide attempt ( p < 0.001), anxiety ( p < 0.001), micro- and macrovascular complication ( p = 0.028 and p < 0.001), education ( p = 0.001) and place of residence ( p = 0.002). In multivariate analysis, however, only BDI score had significant ( p = 0.03191) association with glycemic control. Conclusion Among primary care patients with type 2 diabetes, the prevalence of depressive symptoms was less frequent than anxiety symptoms. More severe depressive symptoms were associated with worse glycemic control.
No takes yet. Share an insight, caveat, or question.
Hargittay et al. (2022) conducted a cross-sectional in Type 2 diabetes (n=338). Depressive symptoms (BDI score) vs. Lower depressive symptom scores was evaluated on Glycated hemoglobin (HbA1c) level (0.26 percentage point increase per 10-unit BDI increase, 95% CI 0.02-0.50, p=0.03191). Among primary care patients with type 2 diabetes, a 10-unit increase in depressive symptom severity was significantly associated with a 0.26 percentage point increase in HbA1c.
Synapse has enriched 10 related papers. Consider them for comparative context: